CA Patent

CA3242833A1 — OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND THEIR USES

Assigned to Alcon Inc · Expires 2023-06-22 · 3y expired

What this patent protects

Patent listed against Tryptyr.

Drugs covered by this patent

Tryptyr (ACOLTREMON) · Alcon Labs Inc

Patent Metadata

Patent number: CA3242833A1
Jurisdiction: CA
Classification: —
Expires: 2023-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.